TWO:6610

TWi Biotechnology, Inc. · TWO · Healthcare · TWD · FY for 2025

Figures on this page computed 2026-11-08 13:08 UTC

Last close

n/aTWD

Market data

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    TWD
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    TWD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aNet margin

    We do not hold this figure for this company, so there is nothing to place.

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    TWD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aFCF margin

    We do not hold this figure for this company, so there is nothing to place.

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    TWD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.005Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    TWD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    TWD
    • computed

Five bars, one line

lens 7 of 9
n/a
1.69x
2.35x
0.43x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

3 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Salesn/a

    Its own average over 5 years, 37.0M.

  • Profit1.69x

    Its own average over 10 years, -119.9M.

  • Free cash flow2.35x

    Its own average over 10 years, -122.1M.

  • Debt0.43x

    Its own average over 6 years, 6.9M.

  • Pricen/a

    Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 2.35 times.

Profit is 1.69 times its own 10-year average; Free cash flow is 2.35 times its own 10-year average; Debt is 0.43 times its own 6-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 5-year averagen/a

    Not held.

    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    TWD
  • Profit against its own 10-year average1.69
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    TWD
  • Free cash flow against its own 10-year average2.35
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    TWD
  • Debt against its own 6-year average0.43
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    TWD
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    TWD

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.